Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Lueftner, Diana; Brucker, Cosima; Decker, Thomas et al.
Real-world efficacy of ribociclib (RIB) plus aromatase inhibitor (AI)/fulvestrant (FUL), or endocrine monotherapy (ET), or chemotherapy (CT) as first-line (1L) treatment (tx) in patients (pts) with hormone receptor-positive (HR plus ), human epidermal growth factor receptor-2-negative (HER2-) advanced breast cancer (ABC): Results of fourth interim analysis (IA) from RIBANNA.JOURNAL OF CLINICAL ONCOLOGY. Bd. 40. H. 16. 2022
Luftner, Diana; Brucker, Cosima; Decker, Thomas et al.
Real-world efficacy of ribociclib plus aromatase inhibitor/fulvestrant, or endocrine monotherapy, or chemotherapy as first-line treatment in women with hormone receptor-positive (HR plus ), human epidermal growth factor receptor-2-negative (HER2-) locally advanced or metastatic breast cancer: Fourth interim analysis from the RIBANNA studyCANCER RESEARCH. Bd. 82. H. 4. 2022
Hess, Georg; Dreyling, Martin; Oberic, Lucie et al.
Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR-2 retrospective chart review studyBRITISH JOURNAL OF HAEMATOLOGY. 2022
Erdmann, Friederike; Raaschou-Nielsen, Ole; Hvidtfeldt, Ulla Arthur et al.
Residential road traffic and railway noise and risk of childhood cancer: A nationwide register-based case-control study in DenmarkENVIRONMENTAL RESEARCH. Bd. 212. 2022
Schwab, Roxana; Droste, Annika; Stewen, Kathrin et al.
Resilience as a Source of Easement to Health-Related Worries in Women at Increased Risk for Breast or Ovarian Cancer During the COVID-19 PandemicINTERNATIONAL JOURNAL OF GENERAL MEDICINE. Bd. 15. 2022 S. 7039-7052
Woelber, Linn; Hampl, Monika; Eulenburg, Christine Zu et al.
Risk for Pelvic Metastasis and Role of Pelvic Lymphadenectomy in Node-Positive Vulvar Cancer-Results from the AGO-VOP.2 QS Vulva StudyCANCERS. Bd. 14. H. 2. 2022
Dudley, Isabelle M.; Sunguc, Ceren; Heymer, Emma J. et al.
Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup studyCANCER. Bd. 129. H. 3. 2022 S. 426-440
Sunguc, Ceren; Hawkins, Michael M.; Winter, David L. et al.
Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup studyBRITISH JOURNAL OF CANCER. Bd. 128. H. 1. 2022 S. 80-90
Lecuru, F.; Sehouli, J.; Vergote, I. B. et al.
Role of CA125 in patients included in the DESKTOP III/ENGOT-ov20 trialANNALS OF ONCOLOGY. Bd. 33. H. 7. 2022 S. S809-S809
Heitz, F.; Sehouli, J.; Fotopoulou, C. et al.
Role of cytoreductive Surgery in Patients who did not undergo Surgery for first Recurrence: A Sub-analysis of the DESKTOP III StudyGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 82. H. 10. 2022 S. E86-E87